Form 8-K - Current report:
SEC Accession No. 0001193125-23-249567
Filing Date
2023-10-03
Accepted
2023-10-03 08:12:59
Documents
14
Period of Report
2023-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d462278d8k.htm   iXBRL 8-K 26376
2 EX-99.1 d462278dex991.htm EX-99.1 12628
6 GRAPHIC g462278dsp07.jpg GRAPHIC 4305
  Complete submission text file 0001193125-23-249567.txt   168107

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA synh-20231003.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE synh-20231003_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE synh-20231003_pre.xml EX-101.PRE 10822
8 EXTRACTED XBRL INSTANCE DOCUMENT d462278d8k_htm.xml XML 3236
Mailing Address 1030 SYNC STREET MORRISVILLE NC 27560
Business Address 1030 SYNC STREET MORRISVILLE NC 27560 919-876-9300
Syneos Health, Inc. (Filer) CIK: 0001610950 (see all company filings)

EIN.: 273403111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36730 | Film No.: 231301594
SIC: 8731 Services-Commercial Physical & Biological Research